Segments - ESR Analyzer Market by Type (Big Sample Numbers and Small Sample Numbers), Application (Scientific Research Purposes, Medical Use, Teaching Use and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2024 – 2032
The global ESR analyzer market size was USD 64.7 Million in 2023 and is likely to reach USD 103.0 Million by 2032, expanding at a CAGR of 5.3% during 2024–2032. The market growth is attributed to the growing prevalence of chronic disease and increasing demand for advanced diagnostic testing.
ESR (Erythrocyte Sedimentation Rate) Analyzers are diagnostic device that are used to screen patients with fevers, muscular pain, and other joint concerns. ESR analyzers are medical devices used to measure the rate at which red blood cells settle to the bottom of a test tube. Manufacturers are focusing in the research and development to launch advanced ESR analyzer devices.
Increasing number of chronic conditions and various health hazards is contributing to the large market. ESR analyzers are widely used in hospitals, clinics, and research institutions to diagnose and monitor various medical conditions. They are an important tool in the diagnosis and management of many diseases and are an essential part of a healthcare provider's diagnostic toolkit.
Artificial Intelligence is revolutionizing the ESR analyzers by the increasing adoption of the AI-powered ESR analyzers, designed to improve the accuracy, efficiency, and the speed of the testing process. Moreover, the reduced cost of the AI-powered ESR analyzers by reducing the need for manual analysis and reducing the need for multiple tests as well.
Growing prevalence of chronic disease that requires rapid test results is driving the market. Disease such as diabetes hypertension, and cardiovascular disease is increasing, driving the demand for diagnostic testing. Furthermore, the increasing demand for advanced diagnostic testing is fueling the global market significantly.
High cost of the advanced ESR analyzers and limited availability in the market is hindering the global market. The ESR analyzers are a sensitive device that diagnose inflammations in the body. Manufacturing these devices is an expensive process and requires experts. This tedious and expensive process results in the high cost of the device, restraining the market.
Increasing adoption of point-of-care testing devices is expected to propel the demand for the ESR analyzers. The surge in the remote patient monitoring solutions and handheld ESR analyzers is rising the adoption rates of these in diagnostic centers. Moreover, the increasing demand for mobile health and diagnostics is expected to drive the global market during the forecast period.
The market report includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
ESR Analyzer Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2023 |
Historic Data |
2017–2022 |
Forecast Period |
2024–2032 |
Segmentation |
Type (Big Sample Numbers and Small Sample Numbers), and Application (Scientific Research Purposes, Medical Use, Teaching Use and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
Key Players Covered in the Report |
ALCOR Scientific; Alifax; Beijing Succeeder; DIESSE Diagnostica; Disera; ELITechGroup; HemaTechnologies; JOKOH; RR Mechatronics; SFRI; and Streck. |
In terms of region, the global ESR analyzer market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Asia Pacific dominates the global market in 2023 owing to the growing healthcare industries. Asia Pacific is home to a large population and a growing healthcare industry, with many countries such as China, Japan, and South Korea having a high demand for ESR analyzers. Many countries in Asia Pacific, such as China and India, have experienced rapid economic growth, leading to an increase in healthcare spending and investment in healthcare infrastructure.
The market in North America is projected to grow at a significant pace in the years to come owing to well-established healthcare systems. Moreover, the high demand for diagnostic testing is expected to fuel the regional market during the forecast period. The United States is a major market for ESR analyzers in North America, with many hospitals and clinics using these devices for routine testing and diagnosis.
Based on type, the ESR analyzer market is divided into big sample numbers and small sample numbers. The small sample numbers segment held the largest share in the global market in 2023 owing to small samples being highly used in the hospitals. Additionally, the small samples are an affordable alternative for the diagnostic purpose fueling the segment.
The big sample numbers segment is anticipated to grow at a substantial CAGR during the forecast period due to the use of these samples in the research purposes. Big sample numbers are highly utilized in research fields for as studying the effects of certain medications or diseases. big sample numbers segment is highly used in research institutions, universities, and pharmaceutical companies for research and development purposes, boosting the segment.
On the basis of application, the global market is segregated into scientific research purposes, medical use, teaching use and others. The medical use segment is anticipated to register a considerable CAGR in over the predicted period due to the increasing demand and awareness for routine diagnosis. The diagnosis of various diseases such as infectious disease, autoimmune disorders, and inflammatory conditions, is propelling the segment. There is a high demand for ESR analyzers in the medical field due to the need for accurate and timely diagnosis of diseases
The scientific research purposes segment is projected to register a robust growth rate during the assessment years owing to the increasing research and developmental activities. The increasing investments in medical research and diagnostic assessments for future medicines is propelling the segment. Additionally, the increasing use of ESR in research institutes, universities, and pharma companies is driving the segment significantly.
The ESR analyzer market has been segmented on the basis of
Key players competing in the global ESR analyzer market are ALCOR Scientific; Alifax; Beijing Succeeder; DIESSE Diagnostica; Disera; ELITechGroup; HemaTechnologies; JOKOH; RR Mechatronics; SFRI; and Streck.